Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension

Canadian Family Physician

Volumn 59, Issue 2, 2013, Pages

  Natarajan, Nandini ^a   Putnam, Wayne ^a   Van Aarsen, Kristine ^a   Lawson, Beverley ^a   Fred Burge, ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ANXIETY DISORDER; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DIABETIC PATIENT; DIETARY INTAKE; DISEASE DURATION; EDUCATIONAL STATUS; ETHNICITY; EXERCISE; FEMALE; GENDER; GENERAL PRACTICE; GENERAL PRACTITIONER; GLYCEMIC CONTROL; HEALTH; HEALTH BEHAVIOR; HEALTH BELIEF; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MORISKY SCALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE PRACTITIONER; PATIENT COMPLIANCE; PREDICTION; RATING SCALE; REVIEW; SELF MONITORING; SELF REPORT; SMOKING; SODIUM RESTRICTION; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; CANADA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; FAMILY PRACTICE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN-PATIENT RELATIONS; SELF REPORT; SODIUM CHLORIDE, DIETARY;

EID: 84874377730     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Harris SB, Ekoé J, Zdanowicz Y, Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the Diabetes in Canada Evaluation Study). Diabetes Res Clin Pract 2005;70(1):90-7.
2. Supina AL, Guirguis LM, Majumdar SR, Lewanczuk RZ, Lee TK, Toth EL, et al. Treatment gaps for hypertension management in rural Canadian patients with type 2 diabetes mellitus. Clin Ther 2004;26(4):598-606.
3. Putnam W, Buhariwalla F, Lacey K, Foodfellow M, Goodine RA, Hall J, et al. Drug management for hypertension in type 2 diabetes in family practice. Can Fam Physician 2009;55:728-34.
4. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001;37(4):1053-9.
5. Canadian Hypertension Education Program. Management of hypertension for people with diabetes. Clinical paper. Markham, ON: Hypertension Canada; 2011. Available from: www.hypertension.ca//images/stories/dls/HTN-Diabetes/2011- ManagementOfHypertensionForPeopleWithDiabetes ClinicalPaperEN.pdf. Accessed 2013 Jan 14.
6. McLean DL, Simpson SH, McAlister FA, Tsuyuki RT. Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies. Can J Cardiol 2006;22(10):855-60.
7. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 2003;26(5):1408-12.
8. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166(17):1836-41.
9. Kettani FZ, Draomir A, Côté R, Roy L, Bérard A, Blais L, et al. Impact of better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009;40(1):213-20. Epub 2008 Nov 28.
10. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009;120(16):1598-605. Epub 2009 Oct 5.
11. Esposti LD, Saragoni S, Benemei S, Batacchi P, Geppetti P, Di Bar M, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res 2011;3:47-54. Epub 2011 Mar 7.
12. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19(4):357-62.
13. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26(5):331-42.
14. World Health Organization. Hypertension in adherence to long-term therapies: evidence for action. Geneva, Switz: World Health Organization; 2003.
15. Statistics Canada. Canadian Community Health Survey. Detailed information, 2005. Ottawa, ON: Statistics Canada; 2006. Available from: www5.statcan. gc.ca/bsolc/olc-cel/olc-cel?catno=82-576-X&CHROPG=1&lang= eng. Accessed 2013 Jan 14.
16. Statistics Canada. National Population Health Survey (NPHS). Ottawa, ON: Statistics Canada; 2004. Available from: www.statcan.gc.ca/concepts/nphs-ensp/ index-eng.htm. Accessed 2013 Jan 14.
17. International physical activity questionnaires. IPAQ: short. Last 7 days selfadministered format. Geneva, Switz: The IPAQ Group; 2002. Available from: www.ipaq.ki.se. Accessed 2013 Jan 14.
18. Bayliss EA, Ellis JL, Steiner JF. Subjective assessments of comorbidity correlate with quality of life health outcomes: initial validation of a comorbidity assessment instrument. Health Qual Life Outcomes 2005;3:51.
19. Oliveria SA, Chen RA, McCarthy BD, Davis CC, Hill MN. Hypertension knowledge, awareness, and attitudes in a hypertensive population. J Gen Intern Med 2005;20(3):219-25.
20. Stewart J, Brown K, Kendrick D, Dyas J; Nottingham Diabetes and Blood Pressure Study Group. Understanding of blood pressure by people with type 2 diabetes: a primary care focus group study. Br J Gen Pract 2005;55(513):298-304.
21. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24(1):67-74.
22. Sung JC, Nichol MB, Venturini F, Bailey KL, McCombs JS, Cody M. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care 1998;4(10):1421-30.
23. Krapek K, King K, Warren S, George K, Caputo D, Mihelich K, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 2004;38(9):1357-62. Epub 2004 Jul 6.
24. Venturini F, Nichol MB, Sung JC, Bailey KL, Cody M, McCombs JS. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother 1999;33(3):281-8.
25. George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2000;50(2):166-71.
26. Turbí C, Herrero-Beaumont G, Acebes JC, Torrijos A, Graña J, Miguelez R, et al. Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study. Clin Ther 2004;26(2):245-56.
27. Patel RP, Taylor SD. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother 2002;36(1):40-5.
28. Gascón JJ, Sánchez-Ortuño M, Llor B, Skidmore D, Saturno PJ; Treatment Compliance in Hypertension Study Group. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract 2004;21(2):125-30.
29. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47(6):555-67.
30. Dillman DA. Mail and telephone surveys: the total design method. New York, NY: John Wiley & Sons; 1978.
31. Salant P, Dillman DA. How to conduct your own survey. New York, NY: John Wiley & Sons; 1994.
32. Grégoire JP, Moisan J, Guibert R, Ciampi A, Milot A, Gaudet M, et al. Determinants of discontinuation of new courses of antihypertensive medications. J Clin Epidemiol 2002;55(7):728-35.
33. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(Suppl 1):S1-201.
34. Putnam W, Lawson B, Buhariwalla F, Goodfellow M, Goodine RA, Hall J, et al. Hypertension and type 2 diabetes: what family physicians can do to improve control of blood pressure -an obersational study. BMC Fam Pract 2011;12:86.
35. Friedman O, McAlister FA, Yun L, Campbell NR, Tu K; Canadian Hypertension Education Program Outcomes Research Taskforce. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario. Am J Med 2010;123(2):173-81.
36. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione C, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 2008;23(5):588-94. Epub 2008 Mar 4.
37. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005;118(Suppl 5A):27S-34S.
38. Vawter L, Tong X, Gemilyan M, Yoon PW. Barriers to antihypertensive medication adherence among adults -United States, 2005. J Clin Hypertens (Greenwhich) 2008;10(12):922-9.
39. Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR. Predictors of compliance with antihypertensive therapy in a high-risk Medicaid population. J Natl Med Assoc 2009;101(1):34-9.
40. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy 2006;26(4):483-92.
41. Ren XS, Kazis LE, Lee A, Zhang H, Miller DR. Identifying patient and physician characteristics that affect compliance with antihypertensive medications. J Clin Pharm Ther 2002;27(1):47-56.
42. Yang Y, Thumula V, Pace P, Banahan F, Wilkin N, Lobb W. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther 2009;31(10):2178-88.
43. Grégoire J, Moisan J, Guibert R, Ciampi A, Milot A. Predictors of selfreported noncompliance with antihypertensive drug treatment: a prospective cohort study. Can J Cardiol 2006;22(4):323-9.
44. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007;120(1):26-32.
45. Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U. Adherence to cardiovascular disease medications: does patientprovider race/ethnicity and language concordance matter? J Gen Intern Med 2010;25(11):1172-7